• Restylane Lyft Approved for Midface Injection via Cannula

    26 days ago - By Surgical Aesthetics Magazine

    Galderma Laboratories has received U.S. Food and Drug Administration approval for the use of Restylane Lyft, a hyaluronic acid dermal filler, with a small blunt tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.
    The approval was based on a 16-week multicenter, open-label, prospective study of 60 male and female subjects that assessed the safety and efficacy of Restylane Lyft with lidocaine for cheek augmentation and the correction of age-related midface contour deficiencies in conjunction with the use of a small...
    Read more ...